GSK reduces AIDS drug price for poor
Glaxosmithkline world's largest maker of HIV/AIDS drugs, said it had nearly halved the price of its leading Combivir treatment in poor countries to 90 US cents a day. The move is the latest sign the
Glaxosmithkline world's largest maker of HIV/AIDS drugs, said it had nearly halved the price of its leading Combivir treatment in poor countries to 90 US cents a day. The move is the latest sign the